Drug intelligence / Profile preview

CTP0302-B

Development stage: Phase 3
Lead developer: Taejoon Pharmaceutical

Overview

CTP0302-B is an investigational drug evaluated in a phase 3 clinical trial for bowel preparation prior to colonoscopy. The available information indicates it is being compared with an active control arm to assess its efficacy in colon cleansing for patients undergoing colonoscopy. Specific details regarding its mechanism of action, chemical composition, or pharmacological class are not provided in the available sources[1].

Beyond the preview

Go deeper on CTP0302-B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CTP0302-B.

Explore the full profile